Viewing Study NCT00074867


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-05 @ 12:12 PM
Study NCT ID: NCT00074867
Status: COMPLETED
Last Update Posted: 2006-11-07
First Post: 2003-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module